Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus

Jie Meng, Rui Yan, Chen Zhang, Xueyan Bai, Xingsheng Yang, Yu Yang, Tao Feng, Xin Liu · 2023

Read Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus by Jie Meng, Rui Yan, Chen Zhang, Xueyan Bai, Xingsheng Yang, Yu Yang, Tao Feng, Xin Liu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712048.txt.

Description

Jie Meng leads a team that pools trials of diabetes drugs and mind function. Their pooled study from twenty twenty-three deals with DPP-4 inhibitors. Type two diabetes raises the risk of mind decline.

Four data bases were searched from the start to a set date. Six clinical trials with thousands of patients were pooled. Mind state scores were compared across the drug groups. The drug class linked in general to score gains. Spread between studies was measured with standard tests. Sensitivity checks dropped one study at a time. Bias checks rounded out the analysis.

Catalog record

CREATORJie Meng, Rui Yan, Chen Zhang, Xueyan Bai, Xingsheng Yang, Yu Yang, Tao Feng, Xin Liu
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10712048

Browse the full library · About the Tower of Babel